Squarepoint’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-43,984
| Closed | -$448K | – | 2978 |
|
|
2025
Q1 | $448K | Buy |
+43,984
| New | +$448K | ﹤0.01% | 1981 |
|
|
2024
Q4 | – | Sell |
-4,525
| Closed | -$263K | – | 3027 |
|
|
2024
Q3 | $263K | Sell |
4,525
-15,307
| -77% | -$889K | ﹤0.01% | 2065 |
|
|
2024
Q2 | $906K | Buy |
+19,832
| New | +$906K | ﹤0.01% | 1423 |
|
|
2022
Q4 | – | Sell |
-19,919
| Closed | -$749K | – | 2474 |
|
|
2022
Q3 | $749K | Buy |
19,919
+2,204
| +12% | +$82.9K | ﹤0.01% | 1210 |
|
|
2022
Q2 | $489K | Buy |
+17,715
| New | +$489K | ﹤0.01% | 1378 |
|
|
2021
Q1 | – | Sell |
-9,035
| Closed | -$637K | – | 2808 |
|
|
2020
Q4 | $637K | Buy |
+9,035
| New | +$637K | ﹤0.01% | 1332 |
|